Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Farallon Capital Management, L.L.C. reported a 8.50% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 3, 2026

Farallon Capital Management, L.L.C. reported a 8.50% stake in Crinetics Pharmaceuticals, Inc., 8,989,098 shares, as a passive investor on Jun 30, 2026. Filed Aug 3, 2026 (Schedule 13G/A).

Stake
8.50%
Shares
8,989,098
Intent
Passive
What changed
Stake changed
Filed together
29 holders

The filing in full

HolderStakeShares
Farallon Capital Management, L.L.C.8.50%8,989,098
Farallon Capital Partners, L.P.0%0
Farallon Capital Institutional Partners, L.P.0%0
Farallon Capital Institutional Partners II, L.P.0%0
Farallon Capital Institutional Partners III, L.P.0%0
Four Crossings Institutional Partners V, L.P.0%0
Farallon Capital Offshore Investors II, L.P.0%0
Farallon Capital (AM) Investors, L.P.0%0
Farallon Capital F5 Master I, L.P.0%0
Farallon Healthcare Partners Master, L.P.0%0
Farallon Partners, L.L.C.0%0
Farallon Institutional (GP) V, L.L.C.0%0
Farallon F5 (GP), L.L.C.0%0
Farallon Healthcare Partners (GP), L.L.C.0%0
Dapice Joshua J.8.50%8,989,098
Dreyfuss, Philip D.8.50%8,989,098
Dunn Hannah E.8.50%8,989,098
Gehani, Varun N.8.50%8,989,098
Giauque, Nicolas8.50%8,989,098
Husen, Avner A.8.50%8,989,098
Kim, David T.8.50%8,989,098
Linn, Michael G.8.50%8,989,098
Luo Patrick (Cheng)8.50%8,989,098
Roberts, Jr., Thomas G.8.50%8,989,098
Saito Edric C.8.50%8,989,098
Short Daniel S.8.50%8,989,098
Spokes, Andrew J. M.8.50%8,989,098
Warren, John R.8.50%8,989,098
Wehrly, Mark C.8.50%8,989,098

Source

View original at SEC

Related